In order to investigate the role of ECF-Zn in regulating the activity of ECF-MMP-2, the membrane-impermeable zinc chelator CaEDTA was microinjected in the lateral ventricle 30min prior to ischemia to remove ECF-Zn that would be generated in the brain during ischemia. Here, MMP2 is linked to ischemia.